-
Annual Review | Dr. Liangyou Gu: Advances in Perioperative Treatment of Renal Cancer in 2024
Renal cancer is a common malignancy of the urinary system. For localized and locally advanced renal cancer without distant or extraregional lymph node metastases, surgical removal of the tumor or the affected kidney remains the primary treatment. Recent advances in targeted therapy and immunotherapy have expanded the options for perioperative treatment of renal cancer. In…
-
CTI 2024丨Dr. Didier Blaise Discusses the Impact of Conditioning Regimens on Transplant Success in Elderly Patients
Q1: Conditioning regimens can affect the incidence of post-transplant complications. How can we balance the intensity of conditioning regimens with reducing the risk of complications for elderly patients? Dr. Didier…
-
CTI 2024丨Dr. Herbert Kim Lyerly: Advances and Future Prospects in Cell and Gene Therapy
Key Highlights Dr. Herbert Kim Lyerly: The current focus of cell and gene therapy lies in its exceptional effectiveness in treating certain cancers, and it is now being extended to…
-
CTI 2024丨Dr. Jean-Luc Harousseau on the Advances and Challenges of Immunotherapy in Multiple Myeloma
Q1: How does immunotherapy compare to traditional therapies in terms of strengths and limitations? How can these treatments be balanced in clinical practice? Dr. Jean-Luc Harousseau: Immunotherapy stands apart from…
-
CTI 2024丨Dr. William Hwang Ying Khee Analyzes the Cost-Effectiveness of CAR-T Cell Therapy
Key Highlights Q1: How do you view the cost-effectiveness of CAR-T cell therapy in improving cancer patients’ survival rates and quality of life? What factors influence its cost-effectiveness? Dr. William…
-
CTI 2024丨Dr. Edmund K. Waller Explores VIP-Mediated Immune Checkpoint Pathways
Key Highlights Q1: Could you briefly introduce the current research landscape in cancer immunotherapy, particularly in novel immune checkpoint pathways, and why you chose this area as your focus? Dr.…
-
Dr. Cheng Huang: Overview of Landmark Advances in Innovative Drugs for Lung Cancer in 2024
Oncology Frontier: The 2024 Elite Lung Cancer Symposium has successfully concluded. As the conference chair, could you share the key highlights of this event? Dr. Cheng Huang: The 2024 Elite…
-
Dr. Shusen Wang: Exploration and Breakthroughs in Endocrine Therapy for Advanced Breast Cancer | Northern Breast Cancer Salon Annual Progress Review
The “Northern Breast Cancer Salon Annual Progress Review” was held in Beijing from January 3 to 5, 2025, providing a comprehensive overview of the latest developments in the diagnosis, treatment, and research of breast cancer over the past year. Dr. Shusen Wang from the Sun Yat-sen University Cancer Center presented a summary of the advances…
Connecting Medical Expertise through Media